Qi Li

发表

Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts

Guanting Lu, Xiaoxiang Rong, W. Fan, 2022, Frontiers in Immunology.

Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy

Lei Wang, Baorui Liu, Yudong Qiu, 2022, Frontiers in Oncology.

DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway

Jinzhang Chen, Xiaoyun Hu, G. Yuan, 2020, Annals of medicine.

Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis

Jinzhang Chen, Xiaoyun Hu, Rong Li, 2022, BMC Infectious Diseases.

OTT_A_286169 12683..12693

Jinzhang Chen, Ya-bing Guo, Xiaoyun Hu, 2020 .

Effectiveness and safety of toripalimab, camrelizumab, and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients

W. Huang, Jinzhang Chen, Ya-bing Guo, 2020, Annals of translational medicine.

Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study

M. Chen, Jinzhang Chen, Ya-bing Guo, 2022, Frontiers in Oncology.

Interaction between hepatitis B virus infection and the efficacy of camrelizumab in combination with apatinib therapy in patients with hepatocellular carcinoma: a multicenter retrospective cohort study

W. Huang, W. Fan, Jinzhang Chen, 2021, Annals of translational medicine.

Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients

W. Huang, Qifan Zhang, Jinzhang Chen, 2021, Frontiers in Immunology.

Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

W. Huang, W. Fan, Jinzhang Chen, 2020, OncoTargets and therapy.

Transarterial chemoembolization with/without immune checkpoint inhibitors plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a single center, propensity score matching real-world study

Jinzhang Chen, Xiaoyun Hu, Rong Li, 2024, Discover. Oncology.

Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study.

Jinzhang Chen, Xiaoyun Hu, Rong Li, 2023, International immunopharmacology.